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Synaptic consolidation is a process thought to consolidate memory in the brain. Although lesion studies have mainly implicated the
hippocampus (HPC) in this process, it is unknown which cell type(s) or regions of the HPC might be essential for synaptic consolidation.
To selectively and reversibly suppress hippocampal neuronal activity during this process, we developed a new Gi-DREADD (hM4Di)
transgenic mouse for in vivo manipulation of neuronal activity in freely moving animals. We found that CA1 pyramidal neurons could be
dose-dependently inactivated by clozapine-n-oxide (CNO). Inactivation of hippocampal neurons within 6 h immediately after
conditioned fear training successfully impaired the consolidation of contextual memory, without disturbing cued memory. To
anatomically define the brain subregion critical for the behavioral effects, hM4Di viral vectors were transduced and selectively expressed
in the glutamatergic neurons in either the dorsal or ventral HPC. Significantly, we found that selective inactivation of ventral but not dorsal
glutamatergic hippocampal neurons suppressed the synaptic consolidation of contextual memory.
















































Memory consolidation is a process whereby newly acquired
information is thought to be stabilized gradually from an
initial labile to a permanent state. In pioneering studies in
1900, Müller and Pilzecker (1900) found that newly learned
memories can be disrupted by competing learning tasks
conducted shortly after the original learning episode,
suggesting that new memories are initially in a fragile state
and gradually consolidate over time. Since then, a large
number of studies have confirmed that new memories
are susceptible to a variety of amnestic agents applied
immediately after original learning, including electrocon-
vulsive shock (Duncan, 1949), systemic or local infusion of
protein synthesis inhibitor (Agranoff et al, 1965), and the
genetic manipulation of signaling molecules (for example,
cAMP response element-binding protein (CREB; Kida et al,
2002), N-methyl-D-aspartate receptor (NMDAR; Shimizu
et al, 2000), or calcium/calmodulin-dependent protein
kinase type ii subunit alpha (a-CaMKII; Lisman et al,
2002)). The susceptibility of newly learned memories to
amnestic agents occurs only within a few hours after
initial learning, and dramatically decreases thereafter
(Bourtchouladze et al, 1998; Freeman et al, 1995; Grecksch
and Matthies, 1980; Igaz et al, 2002). This relatively short
time window reflects ongoing changes of intracellular signal
transduction pathways and subsequent modulation of gene
expression and protein synthesis in local neural circuits,
which are all apparently vulnerable to amnestic agents.
The molecular and cellular changes occurring in the
hippocampus (HPC) a few hours after learning, which are
critical for memory consolidation, have been intensively
investigated during the last two decades (Kandel, 2012;
Lisman and Grace, 2005; McGaugh, 2000). Many molecules
have been implicated in this process, including the NMDA
receptor (Shimizu et al, 2000; Tsien et al, 1996), a-CaMKII
(Frankland et al, 2001), protein kinase A (PKA; Abel et al,
1997), protein kinase C (PKC; Sweatt, 1999) and extra-
cellular signal-regulated kinases (ERKs; Chen et al, 2005) to
name just a few. These signal transduction cascades trigger
the activation of transcription factors (CREB, c-fos, and
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Early growth response protein 1 (Egr1)) and subsequent gene
expression. These molecular changes are thought to lead to
structural and morphological alterations and ultimately the
modification of existing synapses in the local neural circuit
(Frankland and Bontempi, 2005; McGaugh, 2000).
The HPC is not a unitary structure, and it is anatomically
and functionally differentiated along its dorsoventral
(septotmeporal) axis (Fanselow and Dong, 2010; Moser
and Moser, 1998). Both the dorsal and ventral HPC has been
implicated in the process of memory consolidation (Bast
et al, 2001; Donley et al, 2005; Frankland et al, 1998; Maren
et al, 1997; McNish et al, 2000; Trivedi and Coover, 2004),
although the respective role(s) of each division and cell
types within each division are unknown. To address the
time window and the regional specificity of the HPC in
memory consolidation, pharmacological, or genetic lesion
methods have been applied to disrupt hippocampal
function after the initial learning (Bast et al, 2001;
Donley et al, 2005; Frankland et al, 1998; Maren et al,
1997; McNish et al, 2000; Trivedi and Coover, 2004).
However, such overt alterations of hippocampal function
could non-specifically disrupt other neuronal processes,
which could then directly or indirectly modulate subsequent
performance in memory tasks. In order to achieve a
high degree of temporal, reversible, and noninvasive
hippocampal neuron inactivation, we utilized both trans-
genic and virally transduced hM4Di DREADD (Designer
Receptor Exclusively Activated by Designer Drug) technol-
ogy. We found that chemogenetic inactivation of only the
ventral hippocampal principal neurons by hM4Di within
6 h immediately after training impaired the consolidation of
contextual memory. Our results demonstrate a striking and
exquisite cell-type-specific control of a distinct phase and
form of memory.
MATERIALS AND METHODS
Generation of TRE-HA-hM4Di Mice
Mice used in the present study were housed in ventilated
cages, with free access to water and standard chow diet. The
housing room had a 12-h light/dark cycle. All procedures
were conducted in strict compliance with the ‘Guide for the
Care and Use of Laboratory Animals’ and approved by
the Institutional Animal Care and Use Committee of the
University of North Carolina. Transgenic mice were
produced by the UNC transgenic core facility. The HA-
tagged hM4Di sequence was cloned into pTRE-Tight
plasmid and after digestion by XhoI/PvuI, 2.0 kb DNA
fragments of TRE-HA-hM4Di were injected into pronucleus
of C57BL/DBA2 hybrid mouse oocytes. Genotyping was
performed by PCR of genomic DNA extracted from tail clips
using the following primers: forward, 50-ACCGTCAGATC
GCCTGGAGA-30; reverse, 50-GACTGTCTGCAGCTGCCTG
TTG-30.
Upon identification, founder TRE-HA-hM4Di mice were
crossed with mice carrying the tetracycline-controlled
transactivator protein (tTA) driven by the CaMKIIa
promoter on a B6/CBA background (The Jackson Labora-
tory, Bar Harbor, ME, USA). These CaMKIIa-tTA mice have
been described previously (Mayford et al, 1996). Double
transgenic mice carrying both the TRE-HA-hM4Di and
CaMKIIa-tTA transgenes were identified as described
above, with the addition of the primers: forward, 50-CGCT
GTGGGGCATTTTACTTTAG-30 and Reverse, 50-CATGTCC
AGATCGAAATCGTC-30.
Immunohistochemistry
Immunohistochemistry was performed to verify expression
of the HA-hM4Di protein as previously described (Abbas
et al, 2009). Briefly, adult mice were anesthetized and
perfused with 4% parafromaldehyde (PFA) in 1X PBS.
Mouse brains were harvested, post-fixed with in 1X PBS/4%
PFA overnight, and then dehydrated in 1X PBS/30% sucrose
until they sank. Brain sections (40 mm) were cut and
mounted onto the coated microscope slides. Brain slides
were permeabilized with 1X PBS/0.4% Triton X-100 for 1 h,
and then blocked with 1X PBS/0.4% Triton X-100 solution
containing 1% bovine serum albumin and 5% normal goat
serum at room temperature for 1 h. Rabbit monoclonal anti-
HA antibody (1 : 500, Cell Signaling) diluted in the blocking
solution was applied to the slides and incubated at 4 1C
overnight. Following the wash with 1X PBS/0.4% Triton
X-100, slides were incubated with either AlexaFluor 488 or
AlexaFluor 594 goat anti-rabbit antibody (1 : 250, Invitro-
gen) diluted in the blocking solution at room temperature
for 2 h. Fluorescent images were collected on a Nikon 80i
Research Upright Microscope (Nikon, Tokyo, Japan)
equipped with the Surveyor Software with TurboScan
(Objective Imaging, Kansasville, WI). Tiled images were
collected with a Qimaging Retiga-EXi camera (Qimaging,
Surrey, BC, Canada).
Immunoprecipitation and Western Blot
Immunoprecipitation (IP) and western blot were performed
to confirm the expression of HA-hM4Di in the brain of
CaMKIIa- hM4Di double transgenic mice. Mice were deeply
anesthetized and their brains were harvested. The brain
tissues were homogenized in ice-cold standard binding
buffer (SBB, 50 mM Tris-HCl, pH 7.4; 10 mM MgCl2; 0.1 mM
EDTA; plus protease and phosphatase inhibitor cocktails
(Roche Diagnostics)) and centrifuged 20 000 g for 30 min at
4 1C. The pellets were re-suspended in 1 ml RIPA buffer
(50 mM Tris-Cl, pH 8.0; 150 mM NaCl, 0.1% SDS, 1% NP-40,
0.5% Na-deoxycholate, plus protease inhibitor cocktail) and
allowed to lyse on ice for 30 min. After centrifuging at
maximum speed for 30 min at 4 1C, detergent-soluble
proteins (4 mg) were pre-cleared with 50 ml sepharose 4B
beads (Sigma), and then incubated with 50 ml wheat germ
agglutinin (WGA)-conjugated agarose beads (Vector Tech-
nology) overnight at 4 1C on a rotary mixer. After five
washes with 1 ml of RIPA buffer, WGA-bound proteins were
eluted by incubating in 50 ml 2X SDS sample buffer at 55 1C
for 10 min. Whole WGA-bound proteins were separated
using SDS-PAGE gel, transferred to PVDF membrane, and
probed with rabbit monoclonal anti-HA antibody (1 : 500,
Cell Signaling) and mouse monoclonal anti-transferrin
antibody (1 : 1000, Invitrogen). The blot was incubated with
chemiluminescent substrate (Thermo Scientific) and im-
aged in a Kodak Imager.
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Mice were decapitated under isoflurane anesthesia. Coronal
slices (300 mm) containing the dorsal HPC were prepared
using a Leica VT1200 vibratome. Slices were transferred to a
submerged recording chamber (Warner Instruments, Ham-
den, CT), where they were perfused with heated, oxygenated
ACSF at a rate of B2 ml/min and allowed to equilibrate for
30 min before electrophysiological recordings. Pyramidal
neurons in the CA1 subregion of the HPC were recorded
under the infrared video microscopy (Olympus). Recording
electrodes (3–5 MO) filled with (in mM) 135 Kþ gluconate,
5 NaCl, 2 MgCl2, 10 HEPES, 0.6 EGTA, 4 Na ATP, 0.4 Na
GTP, pH 7.3, 290–295 mOsmol were used to patch neurons.
Electrical signals from neurons were acquired via a Multi-
clamp 700B amplifier, digitized at 10 kHz, and analyzed
using the Clampfit 10.2 software (Molecular Devices,
Sunnyvale, CA). Voltage-clamp configuration was used to
access neurons at the onset of experiments to assess basal
membrane properties. Several measures were taken to
determine the effect of CNO on intrinsic excitability and
current-evoked excitability of hippocampal neurons in
control and double transgenic mice. First, current-injected
firing was measured using a ramp protocol to determine the
baseline rheobase of the neuron. Next, current-injected
firing was assessed using a step protocol to examine the
relationship between the magnitude of current injected and
the number of action potentials fired, with each step
increasing from the previous by 10 pA. Subsequently,
baseline RMP was re-established, and CNO was bath-
applied for 5 min to determine whether the concentration of
CNO was sufficient to hyperpolarize the neuron. Another
5 min after CNO application, current injection protocols
were performed again to determine whether application of
CNO altered the ability of current injection to induce firing.
Statistical analyses were performed after first assessing
the normality of distributions of data sets. Changes from
baseline for RMP and rheobase were analyzed using paired
t-tests between baseline and post-CNO values, and compar-
isons between groups were made using unpaired t-tests with
Bonferroni’s correction for multiple comparisons when
appropriate. Welch’s corrections were utilized when var-
iances between groups were unequal. Effects of CNO on the
relationship between the magnitude of current injection and
number of action potentials were assessed using repeated
measures ANOVA.
Virus Production and Stereotaxic Injection
The adeno-associated virus (AAV) CaMKIIa::HA-hM4Di-
IRES-mCitrine was constructed by cloning HA-hM4Di-IRES-
mCitrine into an AAV backbone carrying CaMKIIa promoter
using NheI and AscI restriction sites. The recombinant
AAV vectors were stereotyped with AAV8 coat proteins and
packaged by the Vector Core of the University of
North Carolina at Chapel Hill. The titer was about 1 1012
particles/ml. C57BL/6 mice were anesthetized by ketamine/
xylazine solution and secured in a stereotaxic apparatus
(Kopf Instruments, Tujunga, CA), holes were drilled into
the skull, and viruses were delivered bilaterally using a 10-ml
syringe and metal needle (Hamilton, Reno, NV). The
injection volume and flow rate were controlled by a syringe
pump (Harvard apparatus, Holliston, MA). A pulse micro-
injection (40 nl/injection, 80 nl/s rate, 15 injections/site) was
performed to broaden the spread of the viral vector in the
HPC. The needle was left in place for an additional 5 min after
each injection to minimize upward flow of viral solution.
Virus was microinjected bilaterally into dorsal HPC, ventral
HPC, or both, using the following coordinates: dorsal HPC
(anteroposterior (AP)  2.2 mm from bregma, mediolateral
(ML) ±2.0 mm, dorsoventral (DV)  1.7 mm), ventral HPC
(AP  3.2 mm from bregma, ML ±3.5 m, DV  3.0 mm).
Basal Behavioral Tests
CaMKIIa-hM4Di double transgenic mice and single trans-
genic littermate control mice underwent an extensive
regimen of behavioral testing, to verify that DREADD
expression had no intrinsic effects in the absence of CNO.
Mice were B2 months old when testing began. Tests were
given in the following order, with one or two procedures
per week: elevated plus maze, open field activity, light/dark
preference, accelerating rotarod, social approach test,
prepulse inhibition of acoustic startle responses, and spatial
learning and memory in the Morris water maze. A separate
set of wild-type mice with AAV viral microinjection into
ventral HPC were tested for open field activity. Groups
were AAV-CaMKII::EGFP and AAV-CaMKIIa::HA-hM4Di.
All measures were taken by an observer blind to mouse
genotype. Data were analyzed using one-way or repeated
measures analysis of variance (ANOVA). Fisher’s protected
least significant difference (PLSD) tests were used to
compare group means when a significant F value was
determined. For all comparisons, significance was set at
Po0.05. The detailed protocols of basal behavioral tests
were shown in the Supplementary Data.
Fear Conditioning
The conditioned fear was evaluated using a Near-Infrared
Video Fear Conditioning system (MED Associates, St Albans,
VT). In the training phase, mice receive three pairings of a
30-s, 90 dB, 5 kHz tone (conditioned stimulus, CS) and a 2-s,
0.6 mA foot shock (unconditioned stimulus, US). Contextual
memory was evaluated in the original training chamber 24 h
following the training phase. Cued memory was evaluated in
the different context 48 h following the training phase. Levels
of freezing (no movement for 0.5 s) were automatically
measured by the image tracking software (Med Associates,
St Albans, VT).
The effects of hippocampal inactivation on conditioned fear
in CaMKIIa-hM4Di double transgenic mice and control mice
were investigated in three separate experiments. In the first
study, saline or CNO (2 mg/kg) was administered at 0, 2, and
4 h immediately after training, either given standard mouse
chow, or following a 4-week regimen of DOX-containing
chow (to inhibit expression of HA-hM4Di). In a second study,
the window for CNO administration was shifted, so that CNO
(2 mg/kg) was administered at 6, 8, and 10 h following
training. In a third study, CNO (2 mg/kg) was administered at
0, 2, and 4 h immediately after training and mice were tested
for contextual memory 1 month later. The role of hippo-
campal subregions on memory consolidation was investi-
gated using AAV8-CaMKIIa::HA-hM4Di-IRES-mCitrine
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viruses to selectively express hM4Di in either dHPC,
vHPC, or both hippocampal regions. In these studies, CNO
(2 mg/kg) was administered at 0, 2, and 4 h immediately after
training.
Statistical analyses were performed after first assessing
the normality of distributions of data sets. Comparisons
between groups were made using unpaired t-tests. Welch’s
corrections were utilized when variances between groups
were unequal. Comparisons between groups during con-
ditioning, contextual, and cued memory tests were assessed
using repeated measures ANOVA.
RESULTS
Generation and Characterization of CaMKIIa-hM4Di
Double Transgenic Mice
In previous studies, we demonstrated that hM4Di DREADD,
when activated by clozapine-n-oxide (CNO), can hyperpo-
larize and silence cultured hippocampal neurons by
inducing a G protein-coupled inwardly-rectifying potassium
channel (GIRK) response in vitro (Armbruster et al, 2007).
To determine whether expression of hM4Di can modulate
hippocampal principal cell neuronal activity in vivo, we
developed a transgenic mouse line using the Tet-off system
to achieve tissue-specific and tetracycline-controlled ex-
pression of HA-tagged hM4Di. Three founder lines were
generated by pronuclear injection of C57BL/DBA2 hybrid
mouse oocytes and crossed with mice carrying the
tetracycline-controlled tTA under the control of forebrain-
specific CaMKIIa promoter (Figure 1a–c). The expression of
HA-hM4Di protein was verified in double transgenic
progeny by IP/western blot and immunostaining. The
HA-hM4Di protein was revealed to migrate predominantly
as a single 45 kD band in IP/western blot (Figure 1d). One
line (line 2) with higher receptor expression was selected for
further characterization. In this line, HA-hM4Di immuno-
fluorescence was detected in the HPC, cortex, and striatum
(Figure 1e–h). The most intense signals were found in the
subiculum of the HPC, which receives inputs from CA1 and
entorhinal cortical pyramidal neurons and is the main
output of the HPC. Hereafter, we refer to the double
transgenic mice from this line as CaMKIIa-hM4Di mice and
their single transgenic littermate mice as control mice.
In the Tet-off system, the tetracycline derivative, DOX,
can bind tTA and render it incapable of binding to TRE
sequences, thereby preventing transactivation of target
genes. To examine DOX-controlled expression, double
transgenic mice were fed with DOX-containing chow
(200 mg/kg) for 4 weeks. IP/western blot and immunostain-
ing revealed undetectable expression of the HA-hM4Di
protein (Figure 1d and i). The results verified that HA-
hM4Di expression can be temporally controlled by DOX.
Functional Inhibition of Hippocampal Neurons in
CaMKIIa-hM4Di Double Transgenic Mice by CNO
Administration
To verify the functionality of hM4Di expressed in principal
cells of the HPC, we first assessed the effects of 1 and 10 mM
CNO on the resting membrane potential (RMP) of
hippocampal CA1 neurons in CaMKIIa-hM4Di double
transgenic mice and control mice (Figure 2a–c). A
comparison of baseline and post-CNO values revealed that
10mM CNO did not alter the RMP of hippocampal neurons
in control mice (p40.45). In double transgenic mice, 1mM
CNO produced a small but significant hyperpolarization of
CA1 neurons (t(3)¼ 3.38, p¼ 0.043), whereas 10mM CNO
produced a large hyperpolarization (t(5)¼ 7.42, po0.001),
which was significantly larger than the 1mM dose
(t(8)¼ 4.05, p¼ 0.004; see Figure 2a–c). DOX pretreatment
for 4 weeks in CaMKIIa-hM4Di double transgenic mice
completely ablated the ability of 10mM CNO to hyperpolar-
ize CA1 neurons (p40.75). Further, there were no
differences in baseline RMP between CA1 neurons in control
and double transgenic mice (control:  68.4±4.0 pA, double
transgenic:  63.3±1.5 pA; p40.15), suggesting that the
effects of CNO on the RMP of neurons in double transgenic
mice were likely not due to differences in either cell health or
the basal properties of the cells.
We also assessed the effects of CNO on current-injection
firing in these hippocampal neurons (Figure 2d and e). We
found that bath application of 10mM CNO significantly
increased the rheobase (magnitude of current injection
required to produce an action potential) in double transgenic
mice (t(4)¼ 3.87, p¼ 0.018), although not in control mice
(p40.75). Further, 1mM CNO was unable to alter the
rheobase in double transgenic mice (p40.90), and 10mM
CNO was unable to alter the rheobase in double transgenic
mice pretreated with DOX (p40.95). A comparison between
doses in CaMKIIa-hM4Di mice showed that the effect of
10mM CNO was significantly greater than that of 1mM
(t(7)¼ 2.48, p¼ 0.042, Figure 2d and e). However, there were
no differences in the baseline rheobase between CA1 neurons
between doses (unpaired t-test with Welch’s correction;
p40.25), suggesting that the effects of CNO on the rheobase
of neurons in double transgenic mice were likely not due to
differences in cell health or basal ability of neurons to fire.
An evaluation of the effect of CNO on the relationship
between the magnitude of current injection and number of
action potentials showed that in control mice 10mM CNO did
not alter the number of action potentials per magnitude of
current injection from baseline values in CA1 neurons,
demonstrated by a main effect of time (F(1,20)¼ 12.5,
po0.001) but lack of main effect of CNO and a lack of
interaction between CNO and current magnitude (p’s40.95).
A similar result was found with the 1mM dose in double
transgenic mice (time: F(1,20)¼ 26.6, po0.001; other
p’s40.95). On the other hand, 10mM CNO in double
transgenic mice significantly decreased the number of action
potentials per current magnitude, revealed by a significant
interaction between time and CNO (F(1,20)¼ 1.84, p¼ 0.020),
as well as a main effect of time (F(1,20)¼ 53.9, po0.001) and
a trend toward a main effect of CNO (F(1,20)¼ 4.07,
p¼ 0.078; Supplementary Figure S1). However, this effect
was ablated in mice pretreated with DOX, indicated by a main
effect of time (F(1,20)¼ 14.7, po0.001) but no effect of CNO
or interaction (p’s40.65). Taken together, our results suggest
that CNO dose-dependently decreases CA1 neuronal intrinsic
excitability in CaMKIIa-hM4Di mice, thus functionally
inhibiting the firing of CA1 neurons. In control mice,
however, CNO did not alter any measures of excitability,
demonstrating that the effects of CNO in double transgenic
mice were not due to nonspecific effects of CNO.
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Selective Disruption of Contextual Memory
Consolidation in CaMKIIa-hM4Di Double
Transgenic Mice
To determine whether the CaMKIIa-hM4Di mice have any
intrinsic behavioral changes in the absence of CNO,
CaMKIIa-hM4Di double transgenic mice and littermate
control mice were examined in a battery of neurobehavioral
tests in their naive state. CaMKIIa-hM4Di mice showed
normal growth, body weights, and mating behavior.
Locomotion, anxiety, motor coordination, sociability, and
sensorimotor gating were comparable between the double
Figure 1 Generation and characterization of CaMKIIa-hM4Di double transgenic mice. (a) The construct used for generation of TRE-hM4Di transgenic
mice. The 2.0-kb XhoI-digested DNA fragments containing TRE-HA-hM4Di were injected into the pronucleus of C57BL/DBA2 hybrid mouse oocytes, and a
transgenic mouse was produced. (b) Generation of CaMKIIa-hM4Di mice. TRE-hM4Di transgenic mouse was crossed with a CaMKIIa( tetracycline-
controlled transactivator protein)-tTA driver line to produce double transgenic mice (CaMKIIa-hM4Di). In double transgenic mice, tTA protein binds to the
TRE promoter to activate the HA-hM4Di gene. In the presence of DOX, tTA protein cannot bind to TRE sequences and the transactivate HA-hM4Di gene.
(c) Genotyping of CaMKIIa-hM4Di double transgenic mice. Lower band (258 bp) represents the TRE-HA-hM4Di transgene, and upper band (468 bp)
represents the CaMKIIa-tTA transgene. (d) Detection of the HA-hM4Di protein in double transgenic mice by IP/western blot. Mouse forebrain membrane
proteins were immunoprecipitated by WGA beads, and then blotted by anti-HA antibody. The HA-hM4Di protein was detected as a 45-kD protein band.
The expression of HA-hM4Di was undetectable when double transgenic mice were maintained on DOX-containing food for 4 weeks. (e–i) Localization of
the HA-hM4Di protein in double transgenic mice. Coronal sections (e–g) of CaMKIIa-hM4Di mouse brain were stained with anti-HA antibody. The results
showed that HA-hM4Di was expressed in pyramidal neurons of mouse forebrain, particularly in the hippocampus. Sagittal sections of double transgenic
mouse brain were stained with anti-HA antibody with either normal chow (h) or DOX chow (i). The signals of HA-hM4Di were undetectable when double
transgenic mice were maintained on DOX chow for 4 weeks.
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transgenic and littermate control mice, as demonstrated in
open-field, elevated plus maze, light/dark preference,
accelerating rotarod, social approach, and prepulse inhibi-
tion of acoustic startle responses (PPI) paradigms
(Figure 3a–h, Supplementary Figure S2). These data
showed that there are no baseline behavioral differences
between double transgenic mice and control mice, in the
absence of CNO.
To determine whether hippocampal expression of hM4Di
has intrinsic effects on learning and memory, we evaluated
the performance of double transgenic mice in a classical
contextual and cued-fear conditioning paradigm. In the
absence of CNO, CaMKIIa-hM4Di and littermate control
mice showed comparable learning in tests of contextual and
cued memory (Figure 4e). We further examined spatial
memory in these mice using the Morris water maze
procedure. There were no significant differences between
double transgenic and littermate control mice in spatial
learning and memory in the water maze (Figure 3i and f).
The results suggested that expression of hM4Di in principle
cells of HPC throughout development has no intrinsic
effects on acquisition, consolidation, and retrieval of long-
term memory.
Previous studies have shown that the synaptic consolida-
tion of contextual memory develops within several hours
after training (Freeman et al, 1995; Grecksch and Matthies,
1980; Igaz et al, 2002). Therefore, we hypothesized that
inactivation of hippocampal neurons by CNO within 6 h
after the initial training might block the synaptic consolida-
tion of contextual memory. Double transgenic and control
mice were presented with three pairings of tone (CS) and
foot-shock (US), and then injected with three doses of CNO
(2 mg/kg) at 0, 2, and 4 h after training. Contextual and cued
memory was assessed 24 and 48 h later, respectively, using
measures of freezing (immobility; Figure 4a). Contextual
memory requires both HPC and amygdala to form and
retrieve the context-fear association (HPC-dependent),
whereas cued memory only requires amygdala to form
and retrieve the discrete cue-fear association (HPC-inde-
pendent; Maren and Fanselow, 1996). CaMKIIa-hM4Di and
Figure 2 Clozapine-n-oxide (CNO) dose-dependently decreased CA1 neuronal intrinsic excitability in CaMKIIa-hM4Di double transgenic mice.
(a) Representative traces of resting membrane potential (RMP) from current-clamp electrophysiological recordings of CA1 pyramidal neurons in
CaMKIIa- hM4Di double transgenic and control mice. (b, c). Five minutes bath application of 10 mM CNO hyperpolarized CA1 pyramidal neurons in double
transgenic mice (po0.001, n¼ 6), which was greater than the 1mM dose (p¼ 0.004, n¼ 4), but 10mM CNO did not affect RMP in control mice or double
transgenic mice pretreated with DOX (p’so0.45, n’s¼ 5 and 6, respectively). (d) Representative traces of current-injected firing in CA1 pyramidal neurons
of CaMKIIa- hM4Di and control animals before (top) and after (middle) CNO administration, and stimulus waveform of current injection ramp used to
determine the minimum current injection required to fire an action potential (rheobase; bottom). (e) The mean change from baseline in the rheobase after
CNO administration, showing that bath application of 10mM, but not 1 mM, CNO decreased the rheobase of CA1 neurons in double transgenic mice
(10 mM: p¼ 0.018, n¼ 5, 1 mM: po0.90, n¼ 4) but not in controls or double transgenic mice pretreated with DOX (p’so0.75, n’s¼ 5 and 5, respectively).
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Figure 3 CaMKIIa-hM4Di mice exhibited normal basal behaviors in the absence of clozapine-n-oxide (CNO). CaMKIIa-hM4Di double transgenic mice
and littermate control mice were examined in a battery of neurobehavioral tests in their naive state. CaMKIIa-hM4Di double transgenic mice showed a
comparable behavior in novelty induced locomotion (a, p¼ 0353, n¼ 11) and stereotypy activity (b, p¼ 0.336, n¼ 11). Double transgenic mice showed a
normal anxiety level in the elevated plus maze test (c, p¼ 0.494, n¼ 9) and light/dark preference test (d, p¼ 0.359, n¼ 9). In the accelerating rotarod test,
hM4Di double transgenic mice showed a normal motor coordination (e, p¼ 0.489, n¼ 9). In the sociability and social novelty test, hM4Di double transgenic
mice showed a comparable preference compared with the littermate control mice (sociability, (f) p¼ 0.843, n¼ 9; social novelty, (g) p¼ 0.621, n¼ 9).
Double transgenic mice also showed a normal sensory-motor gating in prepulse inhibition test (h, p¼ 0.279, n¼ 7). In the Morris water maze test, hM4Di
double transgenic mice showed a comparable escape latency during learning ((i) p¼ 0.395, n¼ 7) and preference to the target quadrant during the memory
test ((j) p¼ 0.934, n¼ 7).
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control mice exhibited similar levels of freezing behavior
during the initial training phase (Figure 4d). However, there
was a dramatic decrease of freezing in double transgenic
mice during the retrieval of contextual memory
(t(31)¼ 4.059, p¼ 0.0003; Figure 4b and d), without any
concomitant group differences in the cued memory test
(t(31)¼ 0.7858, p¼ 0.438; Figure 4c and d). The data
indicate that inactivation of hippocampal neurons by CNO
impairs the synaptic consolidation of HPC-dependent
contextual memory but not HPC-independent cued mem-
ory. To exclude off-target effects of CNO, the expression of
hM4Di transgene was attenuated in double transgenic mice
using DOX food administration for 4 weeks, and then mice
were tested in the fear-conditioning paradigm. There was
no significant difference between double transgenic
mice and control mice in the retrieval of contextual
memory (t(22)¼ 1.076, p¼ 0.294; Figure 4b and f) after
the suppression of hM4Di expression.
To determine whether the 6-h time window after training
is the most critical period for synaptic consolidation, we
injected mice with three doses of CNO (2 mg/kg) at later
time points (6, 8, and 10 h after training), and then tested
contextual fear memory 24 h later. The results showed that
there was no significant difference in freezing between
double transgenic mice and control mice during the
contextual memory test (t(18)¼ 0.6011, p¼ 0.555,
Figure 4g), which suggested that initial synaptic consolida-
tion had been completed by 6 h after training. To determine
whether the disruption of initial synaptic consolidation
within 6 h after training has persistent effects on contextual
memory, double transgenic and control mice were given
three doses of CNO (2 mg/kg) at 0, 2, and 4 h after training.
Remote contextual memory was examined 1 month
following the training phase. CaMKIIa-hM4Di mice ex-
hibited a significant decrease in freezing, compared with the
control mice (t(16)¼ 2.173, p¼ 0.045; Figure 4h). These
findings indicate that disruption of the initial synaptic
consolidation phase leads to long-term impairment of
contextual memory.
Ventral, but not Dorsal, Hippocampal Principal Cells
are Involved in Synaptic Consolidation of Contextual
Memory
Although the hM4Di gene was highly expressed in the HPC
of double transgenic mice, expression also occurred in the
Figure 4 Consolidation of contextual memory was disrupted in CaMKIIa-hM4Di mice when clozapine-n-oxide (CNO) was administrated immediately
after training. (a) Experimental time-line for the fear-conditioning paradigm (b–f). Three doses of CNO (2 mg/kg) or saline were administrated at 0, 2, and 4 h
after training. (b) Double transgenic mice showed a significant decrease in contextual freezing in CNO group (p¼ 0.0003, DTg, n¼ 16, control, n¼ 17) but
not in saline group (p¼ 0.744, n¼ 15) or DOXþCNO group (p¼ 0.294, n¼ 12). (c) There was no significant difference in cued freezing between two
genotypes in all groups. (d–f) There was a comparable performance during training between two genotypes in all three groups. Contextual memory was
shown as the percentage of freezing time in a 1-min block during 5-min test. Only the CNO groups showed a significant difference between double
transgenic and control mice (p¼ 0.0003). The cued memory was shown as the percentage of freezing time during the tone (CS). There was no significant
difference between two genotypes in all groups. (g) Contextual memory was not impaired in double transgenic mice when CNO (2 mg/kg) was given 6, 8,
and 10 h after training. Double transgenic mice showed no significant difference in contextual memory (p¼ 0.555 DTg, n¼ 9, control, n¼ 11). (h) Remote
contextual memory was impaired in double transgenic mice when CNO (2 mg/kg) was given at 0, 2, and 4 h after training, and contextual learning tested 1
month later. CaMKIIa-hM4Di mice exhibited a significant decrease in contextual memory (p¼ 0.045, DTg, n¼ 8, control, n¼ 9).
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cortex and stratium. To confirm the role of HPC in the
synaptic consolidation of contextual memory, we initially
stereotaxically delivered the AAV encoding CaMKIIa::HA-
hM4Di-IRES-mCitrine into the HPC. To cover the majority
of the HPC, virus was bilaterally microinjected into two
portions of HPC, dorsal (dHPC) and ventral HPC (vHPC;
Figure 5a). A pulse injection technique was applied to
broaden the spread of the viral vector in the HPC. As
shown in Figure 5b, HA-hM4Di was highly expressed in
both dHPC and vHPC, where it was expressed in the
pyramidal neurons, but not in the parvalbumin-positive
neurons, in HPC (Supplementary Figure S4). Three weeks
later, animals were trained and given three doses of CNO at
0, 2, and 4 h post training. Similar to the results obtained
with the transgenic mouse line, the animals injected with
HA-hM4Di virus showed a significant decrease in freezing
during the retrieval of contextual memory (t(14)¼ 2.183,
p¼ 0.047), but not the retrieval of cued memory
(t(14)¼ 0.304, p¼ 0.785), compared with EGFP control
mice (Figure 5c).
Figure 5 Ventral, but not dorsal, hippocampus was involved in synaptic consolidation of contextual memory. (a) Schematic representation of viral delivery
to the dorsal hippocampus (dHPC), ventral hippocampus (vHPC), or both (HPC). CaMKIIa::HA-hM4Di-IRES-mCitrine or CaMKIIa::EGFP viral vectors were
bilaterally injected into dHPC, vHPC, or both. (b) Immunostaining of mouse brain delivered with CaMKIIa::HA-hM4Di-IRES-mCitrine virus. HA-hM4Di was
expressed in the dorsal hippocampus, ventral hippocampus, or both in hM4Di-dHPC, hM4Di-vHPC, or hM4Di-HPC mice, respectively. Scale bar: 1 mm.
(c) Ventral, but not dorsal, hippocampus was involved in synaptic consolidation of contextual memory. Three weeks after viral delivery, animals were trained
and administrated with three doses of clozapine-n-oxide (CNO; 2 mg/kg) at 0, 2, and 4 h after training. Contextual and cued memories were tested 24 and
48 h later, respectively. Mice with HA-hM4Di viruses injected into both dHPC and vHPC showed a significant decrease in contextual memory compared
with the control mice (p¼ 0.047, n¼ 8). Mice with HA-hM4Di viruses injected into only vHPC showed a significant decrease in contextual memory
(p¼ 0.015, n¼ 10). However, mice with HA-hM4Di virus injected into only dHPC showed a similar freezing compared with the control mice in contextual
memory (p¼ 0.795, n¼ 7). (d) Synaptic consolidation was not impaired by administration of CNO before training in hM4Di-vHPC mice. HA-hM4Di viruses
were delivered to the vHPC. Three weeks later, mice were administrated with CNO (2 mg/kg) 30 min before, instead of after training. There was no
significant difference in contextual memory between hM4Di-vHPC and control mice (p¼ 0.87, n¼ 9).
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Prior anatomical studies indicated that the input and
output connections of dHPC and vHPC are distinct, and
that vHPC, but not dHPC, is involved in emotional behavior
(Fanselow and Dong, 2010; Moser and Moser, 1998). To
determine which portion of the HPC is involved in the
synaptic consolidation of contextual memory, we stereo-
taxically delivered CaMKIIa::HA-hM4Di-IRES-mCitrine
virus into dHPC or vHPC of mouse brain, and assessed
their role in synaptic consolidation using the aforemen-
tioned fear-conditioning protocol. Following treatment
with CNO, mice expressing HA-hM4Di virus in the vHPC
showed a significant decrease in freezing during the
retrieval of contextual memory (t(18)¼ 2.7, p¼ 0.015),
although mice expressing HA-hM4Di virus in the dHPC
were unaffected by CNO (t(12)¼ 0.266, p¼ 0.795), com-
pared with EGFP control mice (Figure 5c). Our data
demonstrate that suppressing glutamatergic neuronal activ-
ity in the vHPC, but not dHPC, selectively impairs synaptic
consolidation of contextual memory.
We thus demonstrate that the time window immediately
after training was critical for the synaptic consolidation in
the HPC, and vHPC, but not in dHPC principal cells, had
a major role during this process. To further confirm the
time-specific effect of CNO on synaptic consolidation in
vHPC, we stereotaxically delivered CaMKIIa::HA-hM4Di-
IRES-mCitrine virus into the vHPC of a separate cohort of
mice and administered 2 mg/kg CNO 30 min before
training. We found that there was no significant difference
in contextual freezing between HA-hM4Di viral-delivery
mice and EGFP control mice (t(16)¼ 0.167, p¼ 0.87;
Figure 5d). The results show that suppressing glutamater-
gic neurons in the vHPC immediately after, but not before,
training impairs synaptic consolidation of contextual
memory.
DISCUSSION
The main finding of this paper is that the acute chemoge-
netic inactivation of ventral hippocampal principal cells is
sufficient to impair synaptic consolidation of memory using
a contextual fear-conditioning paradigm. These findings
demonstrate a novel and striking cell type and regionally
selective modulation of synaptic consolidation of memory.
We also report and characterize a Gi-DREADD (hM4Di)
transgenic mouse line for in vivo manipulation of neuronal
activity in freely moving mice. Finally, these findings serve to
validate the use of chemogenetic technology such as hM4Di
to reversibly and non-invasively modulate the activity of
hippocampal neurons.
Synaptic consolidation is a process thought to be required
to stabilize synaptic changes after learning and has been
reported to involve gene expression, de novo protein
synthesis, and synaptic restructuring (Dudai, 2004;
Frankland and Bontempi, 2005). Previous studies
(Bourtchouladze et al, 1998; Freeman et al, 1995; Igaz
et al, 2002; Quevedo et al, 1999) have shown that there are
two critical time windows for the synaptic consolidation
of contextual memory: around the time of training and
3–6 h after training. In the present study, we found that
inactivating hippocampal neurons by CNO administration
in the initial 6 h immediately after training led to selective
impairment of contextual fear conditioning. However, CNO
administration beyond this 6-h window or immediately
before training was unable to block synaptic consolidation.
The brief window of synaptic consolidation is not only
important for recent contextual memory (Bourtchouladze
et al, 1998; Freeman et al, 1995; Igaz et al, 2002; Quevedo
et al, 1999) but also for 1-month-old remote contextual
memory as shown in our paper, suggesting that the initial
synaptic consolidation phase is critical for subsequent
system consolidation.
In the current study, we selectively blocked the synaptic
consolidation by chemogenetic inactivation of hippocam-
pal neurons immediately after training. We posit that there
are two possible cellular or molecular mechanisms for the
Gi-DREADD-mediated disruption of synaptic consolida-
tion. First, as the NMDA/aCaMKII signaling pathway is
crucial for the long-term potentiation (LTP) and memory
consolidation (Mayford et al, 1995; Rampon et al, 2000;
Silva et al, 1992; Tang et al, 1999; Tsien et al, 1996),
hM4Di receptor could activate a GIRK, induce
hyperpolarization, and block action potential firing in
hippocampal neurons (Armbruster et al, 2007). As
hyperpolarization of neurons prevents the activation of
NMDA receptors, it could subsequently blocks LTP
and memory consolidation (Malinow and Miller, 1986).
Second, the cAMP/PKA/CREB signaling transduction
pathway has been shown to be involved in the main-
tenance of LTP and synaptic consolidation (Abel et al,
1997; Kida et al, 2002; Pineda et al, 2004; Pittenger et al,
2002; Wang et al, 2004; Wong et al, 1999). As the
Gi-DREADD receptor is coupled to the Gi/o protein, when
it is activated by CNO, the Gi/o protein will be released and
it will diminish the activity of adenylyl cyclase (AC). A
decrease in intracellular cAMP concentration could there-
by prevent the activation of PKA and subsequent
phosphorylation of CREB. Ultimately, CREB-mediated
gene expression, which is important for the memory
consolidation (Kandel, 2001, 2012), is disrupted. Although
the current studies do not directly address the mechan-
ism(s) involved, it is possible that Gi-DREADD might
compromise both signaling pathways and thereby attenu-
ate synaptic consolidation.
The HPC has been shown to be functionally defined
along its dorsoventral axis (Fanselow and Dong, 2010;
Moser and Moser, 1998; Pitkanen et al, 2000; Richmond
et al, 1999; Yoon and Otto, 2007). The dHPC receives a
dense input from the lateral entorhinal cortex and is
proposed to participate in processing exteroceptive
sensory information, whereas the vHPC receives inputs
from the medial entorhinal cortex and is proposed to assist
in processing interoceptive sensory information (Amaral,
1995). Thus, the dHPC is thought to have a predominant
role in spatial memory, whereas the vHPC is thought to be
important for the consolidation of memories associated
with anxiety and emotional behavior (Fanselow and Dong,
2010). We have built on and extended these prior studies
by definitively showing, by selective chemogenetic inacti-
vation of the dHPC or vHPC during synaptic consolida-
tion, that vHPC, but not dHPC, was involved in the
consolidation of contextual fear memory. Our findings
clearly support the concept of a functional differentiation
of the HPC along the dorsoventral axis and confirm the
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role of the vHPC in the synaptic consolidation of
contextual memory.
Further, while some prior reports in the literature
suggested a role for the dHPC in the learning or/and
memory for contextual fear (Debiec et al, 2002; Frankland
et al, 1998; Maren et al, 1997; McNish et al, 2000), others
found a role for the vHPC (Ambrogi Lorenzini et al, 1997;
Bast et al, 2001; Donley et al, 2005; Hobin et al, 2006; Rudy
and Matus-Amat, 2005; Trivedi and Coover, 2004; Zhang
et al, 2001). Our results using chemogenetic technology
clearly implicate the vHPC and not dHPC, in the
consolidation of contextual fear memory. There are several
lines of evidence from prior studies that lend support to
these findings. First, as a component of context, olfactory
information is believed to be processed in the vHPC but
not in dHPC (Kent et al, 2007). In fMRI studies, there is a
greater activation of ventral (rodent)/anterior (human)
HPC when odor information is processed (Cerf-Ducastel
and Murphy, 2001; Kent et al, 2007). Further, vHPC lesions
have more pronounced effect on olfactory cues than visual
or spatial cues, whereas the opposite is found for dHPC
lesions (Blanchard et al, 2005; Hunsaker et al, 2008; Kesner
et al, 2011; Levita and Muzzio, 2010). Therefore, inactiva-
tion of vHPC may impair the consolidation of olfactory
memory, and reduced behavioral freezing during the
subsequent contextual test. Second, the vHPC has direct
and extensive connections with the amygdala, whereas the
dHPC gains access to amygdala only through its connec-
tions with vHPC (Pitkanen et al, 2000). Stimulation of the
efferents projecting from vHPC to amygdala regulates
synaptic plasticity in the amygdala, and lesioning of these
efferents prevents contextual fear conditioning (Maren and
Fanselow, 1995). Therefore, chemogenetic inactivation of
vHPC by Gi-DREADD may disrupt the normal commu-
nication between the vHPC and amygdala, block the
converging contextual information from both vHPC and
dHPC to amygdala, and impair the consolidation of
contextual memory.
Previous studies (Bannerman et al, 2003; Kjelstrup et al,
2002; Yoon and Otto, 2007) have reported that lesions or
pharmacological manipulation of vHPC can alter anxiety
and locomotor activity that may non-specifically affect the
performance of behavioral freezing during tests of condi-
tioned fear. In the present study, it is highly unlikely that
the deficit in consolidation of contextual memory was due
to alterations of anxiety or locomotor activity as these were
measured and found to be unaffected by CNO injection
(Supplementary Figure S3).Thus, our findings clearly
demonstrate that deficits in context-dependent freezing
following selective chemogenetic inactivation of vHPC
principal neurons reflect the impairment of synaptic
consolidation, and not a non-specific alteration of anxiety
or locomotor behavior.
In summary, we demonstrate that vHPC principle
neurons are key drivers for synaptic consolidation of
memory.
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